The pharmaceutical pricing, reimbursement and prescribing environment in Canada
by Decision Resources Inc.
This white paper by Decision Resources Inc. presents an overview of the health care system and pharmaceutical market in Canada. It examines drug pricing and reimbursement procedures in detail, and concludes with a brief assessment of the outlook for the Canadian pharmaceutical market. It also discusses price tests used by the Patented Medicine Prices Review Board (PMPRB) and price guidelines for existing and new medicines of Canada. According to Decision Resources, pharmaceutical companies can earn attractive returns on investment in the Canadian market if they are prepared to deal with tough federal pricing regulations and a complex reimbursement environment.
| Published: | 2003 |
| Format: | |
| Length: | 14 pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
